medigraphic.com
Organo Oficial de la Sociedad Mexicana de Urología

2012, Number 5

<< Back Next >>

Rev Mex Urol 2012; 72 (5)

Disfunción eréctil en pacientes con enfermedades crónico-degenerativas y metabólicas en una población rural de Yucatán, México

Pavía-Ruz N, Lope-Gómez M, Vera-Gamboa L

Language: Spanish
References: 13
Page: 240-244
PDF size: 140.30 Kb.


ABSTRACT

Background: Erectile dysfunction (ED) significantly affects the self-esteem of the individual, with repercussions in patient health and quality of life. It has been associated with age, type 2 diabetes mellitus (DM2), and high blood pressure (HBP), among others. ED affects 13% to 28% of men between the ages of 40 and 80 years, worldwide. In Yucatán, there is a high percentage of persons presenting with DM2, HBP, overweight, and obesity, all of which are factors associated with ED.
Methods: A study was conducted at a rural health center in Yucatán from November 2009 to January 2010 to determine ED prevalence in 228 subjects over forty years of age that presented with DM2, overweight, obesity, or HBP. The standardized Sexual Health Inventory for Men (IIEF-5) questionnaire, validated for Spanish, was applied.
Results: Some degree of ED was present in 128/228 subjects (56%); 32% of them were between the ages of 40 and 49 years, and 93% were over 70 years of age. ED prevalence in the DM2 group was 69%. It was 51% in the Overweight-Obesity group, and 48% in the HBP group. A total of 83% of the individuals were prescribed metoprolol.
Conclusions: There was a high prevalence of ED in subjects with DM2, Overweight-Obesity, or HBP and given the large number of members of this population that were affected, it should be considered a public health problem.


REFERENCES

  1. Kevin T. Alteraciones de la función sexual y reproductora. En: Harrison, Principios de medicina interna. 15ª Ed. Mc Graw-Hill. 2004. 345-349.

  2. Consultado el 14 de diciembre de 2009. http://www.fisterra.com/guías2/derectil.asp.

  3. Korenman S. Epidemiology of erectile dysfunction. Endocrine 2004;23(2-3):87-91.

  4. Laumann EO, Nicolosi A, Glasser D, et al. Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res 2005;17(1):39-57.

  5. Venegas J, Baeza R. Prevalencia de disfunción eréctil en chile. Rev Chil Urol 2004;69(3):199-202.

  6. Ugarte y Romano F, Barroso Aguirre J. Prevalencia de disfunción eréctil en México y factores de riesgo asociados. Rev Mex Urol 2001;61(2):63-76.

  7. Fong Mata ER, Azuara Jaramillo A. Prevalencia de disfunción eréctil en pacientes diabéticos. Med Int Mex 2007;23(6):477-480.

  8. Romero CE. Disfunción eréctil y enfermedad cardiovascular. Rev Urug Cardiol 2008;23:65-70.

  9. Consultado el 20 de septiembre de 2012. http://www.insp.mx/ensanut/sur/Yucatan.pdf

  10. Consultado el 01 de octubre de 2012. http://www.minsalud.gov.co/salud/Documents/Gu%C3%ADa%20Metodol%C3%B3gica%20para%20la%20elaboraci%C3%B3n%20de%20gu%C3%ADas.pdf.

  11. Rhoden E, Teloken C, Sogari P, et al. The use of the simplified International Index of Erectile Function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunction. Int J Impot Res 2002;14(4):245-250.

  12. Kassouf W, Carrier S. A comparison of the International Index of Erectile Function and erectile dysfunction studies. BJU Int 2003;91(7):667-669.

  13. Arreola-Ornelas H, García-Mollinedo L, Rosado Buzzo A, et al. Ahorro por el manejo con Sildenafil como coadyuvante en la adherencia al tratamiento farmacológico en hipertensión y diabetes tipo 2 en México. Rev Mex Urol 2008;68(1):21-35.




2020     |     www.medigraphic.com